Report overview
Women's health is a science aimed at maintaining and promoting women's health. It takes groups as its service and research objects, focuses on prevention, and closely integrates with clinical practice. The level of women?s health care in a country is closely linked to the political, economic and social status of women in that country. Over the past 50 years, my country?s women?s health undertakings have made great progress, but there are still many problems with the improvement of women?s health and women?s physical and mental health across the country, and further efforts are needed.?
This report aims to provide a comprehensive presentation of the global market for Women?s Health Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Women?s Health Drugs. This report contains market size and forecasts of Women?s Health Drugs in global, including the following market information:
Global Women?s Health Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Women?s Health Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
EVISTA Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Women?s Health Drugs include Bayer AG, Allergan, Merck & Co, Pfizer Inc, Amgen, Agile Therapeutics Inc, Ferring Pharmaceuticals, Mylan N.V. and Lupin (India), etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Women?s Health Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Women?s Health Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Women?s Health Drugs Market Segment Percentages, by Type, 2022 (%)
EVISTA
XGEVA
Prolia
Mirena
Zometa
Reclast/Aclasta
Minastrin 24 Fe
Others (Premarin, ACTONEL, ORTHO TRI-CY LO)
Global Women?s Health Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Women?s Health Drugs Market Segment Percentages, by Application, 2022 (%)
Hormonal Infertility
Postmenopausal Osteoporosis
Endometriosis
Contraceptives
Menopause
Polycystic Ovary Syndrome
Other Applications
Global Women?s Health Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Women?s Health Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Women?s Health Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Women?s Health Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer AG
Allergan
Merck & Co
Pfizer Inc
Amgen
Agile Therapeutics Inc
Ferring Pharmaceuticals
Mylan N.V.
Lupin (India)
Eli Lilly And Company
Novartis AG
Johnson & Johnson
Outline of Major Chapters:
Chapter 1: Introduces the definition of Women?s Health Drugs, market overview.
Chapter 2: Global Women?s Health Drugs market size in revenue.
Chapter 3: Detailed analysis of Women?s Health Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Women?s Health Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
